Methodological weaknesses in non-randomized studies of ecstasy (MDMA) use: a cautionary note to readers and reviewers.
Teri S
TS
Krebs
Pål-Ørjan
PØ
Johansen
D001921:Brain / Q000187:drug effects* / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008297:Male; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000009:adverse effects*; D018490:Serotonin Agents / Q000009:adverse effects*; D014795:Visual Pathways / Q000187:drug effects* / Q000503:physiopathology*
D018490:Serotonin Agents; D018817:N-Methyl-3,4-methylenedioxyamphetamine